XML 75 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands, € in Millions
 9 Months Ended
Oct. 03, 2015
USD ($)
Oct. 04, 2014
USD ($)
Operating Activities:    
Net income $ 157,587 $ 230,465
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion 63,421 73,477
Stock-based compensation 13,997 14,238
Decrease in allowance for returns-net of inventory in transit (7,981) (727)
Loss on disposal of assets 2,164 643
Impairment losses 5,587 6,083
Non-cash restructuring charges 2,381 0
Decrease in allowance for doubtful accounts (1,867) (351)
Excess tax benefits from stock-based compensation (176) (885)
Deferred income taxes and other 7,458 (1,144)
Contingent consideration remeasurement (114) 1,112
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 103,259 48,385
Inventories (172,746) (146,141)
Prepaid expenses and other current assets (20,669) (49,220)
Accounts payable 17,871 33,216
Accrued expenses (18,618) (26,840)
Income taxes payable (17,064) 15,600
Net cash provided by operating activities 134,490 197,911
Investing Activities:    
Additions to property, plant and equipment (53,171) (70,792)
Increase in intangible and other assets (737) (11,586)
Skagen Designs arbitration settlement 5,968 0
Business acquisitions-net of cash acquired (4,820) 0
Net investment hedge settlement 0 410
Net cash used in investing activities (52,760) (81,968)
Financing Activities:    
Acquisition of common stock (231,220) (321,224)
Distribution of noncontrolling interest earnings and other (5,257) (5,392)
Excess tax benefits from stock-based compensation 176 885
Debt borrowings 1,867,550 637,000
Debt payments (1,691,139) (522,172)
Proceeds from exercise of stock options 658 1,922
Other financing activities (2,097) (1,942)
Net cash used in financing activities (61,329) (210,923)
Effect of exchange rate changes on cash and cash equivalents 4,907 (7,404)
Net increase (decrease) in cash and cash equivalents 25,308 (102,384)
Cash and cash equivalents:    
Beginning of period 276,261 320,479
End of period $ 301,569 $ 218,095